Liu Pi Nan
Liu Pi Nan — Chief Physician — Neurosurgery — Beijing Tiantan Hospital
Specialties
Pituitary tumor, craniopharyngioma, meningioma, schwannoma, nasopharyngeal carcinoma, olfactory neuroblastoma, epidermoid cyst, repair of cerebrospinal fluid leak. Pituitary tumor: non-functioning pituitary adenoma, growth hormone-producing pituitary adenoma, prolactin-producing pituitary adenoma, adrenocorticotropic hormone-producing pituitary adenoma, thyroid-stimulating hormone-producing pituitary adenoma, gonadotropin-producing pituitary adenoma, mixed-functioning pituitary adenoma, various complex pituitary adenomas, recurrent pituitary adenoma. Meningioma: olfactory groove meningioma, tuberculum sellae meningioma, sphenoid ridge meningioma, foramen magnum meningioma, cavernous sinus trigeminal schwannoma, petroclival meningioma and other complex meningiomas.
Education
He successively studied under Academician Han Demin and Academician Wang Zhongcheng.
Professional Experience
Chief Physician, Professor, PhD Supervisor. Currently serving as Deputy Secretary of the Party Committee of the Neurosurgery Center at Beijing Tiantan Hospital, Director of the Seventh Neurosurgical Tumor Ward, Director of the Neurosurgery Reconstruction Department at the Beijing Institute of Neurosurgery, and Discipline Leader in the Beijing health system. He has long been engaged in clinical work in neurosurgery and has completed over 10,000 various neurosurgical operations, particularly specializing in the surgical treatment of intracranial and extracranial communicating tumors, skull base reconstruction techniques, and endoscopic transnasal surgery for skull base lesions. Since performing Beijing Tiantan Hospital's first neuroendoscopic pituitary tumor removal in 2000, he has led a team to complete over 7,000 neuroendoscopic surgeries removing central skull base/intracranial midline tumors and over 3,000 other minimally invasive endoscopic procedures such as cerebrospinal fluid leak repairs. He has also performed over 5,000 cranial base tumor craniotomies, treating diseases including various types of pituitary tumors, craniopharyngiomas, meningiomas, schwannomas, nasopharyngeal carcinoma, neuroblastomas, epidermoid cysts, and other diseases, accumulating unique clinical data and extensive clinical experience. Tumor total resection rates, mortality rates, and neurological function preservation have reached internationally advanced levels. In addition, he has accumulated extensive experience in the comprehensive treatment of neurofibromatosis, establishing the first multidisciplinary team in China for specialized diagnosis, treatment, and research of neurofibromatosis. He has led the compilation of the "Chinese Expert Consensus on Multidisciplinary Collaborative Diagnosis and Treatment Strategies for Neurofibromatosis Type 2" and, as head of the writing team, compiled the "Guidelines for Multidisciplinary Diagnosis and Treatment of Neurofibromatosis Type 1." He spearheaded the establishment of the Neurofibromatosis Committee of the China Rare Disease Alliance and was elected the first chairman. He also maintains good cooperative relationships with multiple international medical and research institutions, such as Massachusetts General Hospital (MGH) and The Johns Hopkins Hospital. He provides the most advanced comprehensive treatment plans for patients with neurofibromatosis in China and is at the forefront of the international clinical and research fields for neurofibromatosis.
Professional Roles
Chairman of the Neurosurgery Branch of the China Medical and Health International Exchange Promotion Association, Chairman of the Neurofibromatosis Professional Committee of the China Rare Disease Alliance, Deputy Chairman of the Neuropsychology Professional Committee of the Chinese Psychological Society, National Committee Member of the Neurosurgery Branch of the Chinese Medical Association, Member of the Brain-Computer Interface Standardization Technical Committee of the Ministry of Industry and Information Technology, Head of the Neuro-Oncology Professional Group of the Neurosurgery Branch of the Beijing Medical Association